Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
accelerate, accelerated, announcement, black, care, compliance, composed, cooperating, costly, damage, dataset, debarment, demand, diagnosed, distraction, drop, employ, Employer, encounter, experimental, field, filer, fulfill, gain, gained, geographic, grow, healthcare, Identification, implementing, individual, infrastructure, ingredient, investigate, investigation, investigational, labeling, list, located, lock, long, lump, maximum, metabolic, moving, NASD, National, NDA, oversee, owed, par, partially, past, perception, pertaining, Pharma, polymer, pose, preceding, prone, pursuit, qualified, qualify, recruit, resold, restrict, retain, rofecoxib, Schwarz, shorter, shown, sought, source, standard, stemming, strictly, sum, Sumitomo, supplier, telephone, Toprol, train, training, underwritten, unilateral, version, Vioxx, voluntarily, widely, withdrew
Removed:
acquired, Alzheimer, approvable, blood, brought, California, capability, comprise, deemed, dementia, difficulty, discretion, documented, dysfunction, element, endothelial, entitle, explored, feet, French, fully, Germany, half, impede, inside, issuer, January, junior, King, line, marginally, Medco, Minnesota, molecule, occasionally, Ontario, original, Parkinson, preclinical, Professor, profile, request, satisfaction, served, short, show, signaling, space, square, stage, stating, statistically, studied, terminable, tested, Tropol, ultimately, validation, vascular, vessel, wall
Filing tables
Filing exhibits
NTMD similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of NitroMed, Inc. (the "Company") for the period ended September 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael D. Loberg, Ph.D., President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
- (1)
- The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
- (2)
- The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 8, 2004 | /s/ MICHAEL D. LOBERG Michael D. Loberg, Ph.D. President and Chief Executive Officer |